The division offers more than 12,000 parameters ranging from routine blood tests to highly advanced diagnostics, covering the entire span from early diagnosis to prevention. Diagnostic tests play an important role at every step of disease management, from screening and diagnosis to monitoring. Furthermore, there is an increasing trend for the general population to focus on well-being and prevention.
In 2023 the division’s revenue amounted to EUR 571.2m and represented 32 per cent of total revenue. 119.2 million tests were processed. The division’s network consists of 118 laboratories, 892 blood-drawing points (BDPs) and 27 clinics in thirteen markets.
To enable efficient delivery of services to customers and at the same time benefiting from scale effects, Diagnostic Services works in a hub-and-spoke model.
- Central and regional laboratories: central laboratories provide advanced diagnostics as well as support for clinical trials. These centralised laboratories act as hubs in their country of operation and conduct routine tests, immunology tests and advanced tests (including histopathology and genetics). The regional laboratories are located around the central laboratories, providing a range of routine and immunology tests with shorter processing times, often with same-day delivery.
- Hospital laboratories: provide urgent diagnostic testing and facilitate off-site access to a broad range of tests.
- Special laboratories: provide centralised services in a dedicated field such as special immunology, genetics and histopathology.
- BDPs operate as collection points for blood, urine and tissue samples. The samples are then transported to Medicover’s laboratories where they are analysed. The BDPs are spread across Poland, Romania, Ukraine and other countries.
- Medicover Clinics: a network of clinics in Germany specialising in endocrinology, HIV, genetics and rheumatology.